Leerink Partners Resumes Agilent (A) at Outperform

November 10, 2016 8:45 AM EST
Get Alerts A Hot Sheet
Price: $47.64 -1.26%

Rating Summary:
    13 Buy, 7 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 23 | Down: 34 | New: 34
Trade A Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Leerink Partners resumes coverage on Agilent (NYSE: A) with a Outperform rating and a price target of $53.00.

Analyst Puneet Souda commented, "We view Agilent positively and believe that: (1) Agilent is still a solid margin expansion story and mid-single-digit grower in our Life Science Tools (LST) universe after it spun off Keysight (its electronic management business) in FY2014 to become a pure-play LST company; (2) Agilent is focused on delivering 22% adjusted operating margins in FY2017 – up 150bps from FY2016 levels, which we believe it will achieve if not exceed under the leadership of CEO McMullen; (3) Agilent competes aggressively in multiple markets – delivering solid double-digit growth in biopharma (27% of sales) and maintains either the #1 or #2 position across most of its other end-markets including food, environmental, and chemical/energy; and (4) as emerging markets including China continue to post double-digit growth, Agilent is positioned to capitalize given sizable exposure to these geographies."

For an analyst ratings summary and ratings history on Agilent click here. For more ratings news on Agilent click here.

Shares of Agilent closed at $45.94 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, New Coverage

Add Your Comment